Back to News
Market Impact: 0.08
Texas Cardiac Arrhythmia Institute pri St. David's Medical Center sa zúčastňuje na skúšaní inovatívneho mapovacieho a pulzného ablačného systému ako prvý v USA
Source: PR Newswire
Healthcare & BiotechTechnology & Innovation
Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center announced it became the first site in the country to participate in a clinical trial evaluating the safety and efficacy of a mapping and pulsed ablation system. The release is primarily institutional/clinical trial participation news without reported outcomes, financial figures, or broader market implications.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
More News
- Intel surges 12% as CPU stocks rally. Here's what's driving the move
- Bitcoin Reaches Eight-Month High After Clarity Act Loss
- Meta's Muse personal AI agent tops ChatGPT, Grok and Claude for post-launch downloads
- Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
- This stock could double if 'tokenization' trend takes on hold on Wall Street
- US stresses backing for Japan, Korea and Taiwan ahead of Trump-Xi summit